Dendritic cell targeted HIV‐1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8+ T cells
Immunity Inflammation and Disease2017Vol. 6(1), pp. 163–175
Citations Over Time
Loveline Ngu, Nadesh Nji, Georgia Ambada, Apeh A. Ngoh, Ghislain Donald Njambe Priso, Jules Tchadji, Abel Lissom, Suzanne H. Magagoum, Carol Ngane Sake, Thibau Flaurant Tchouangueu, George O Chukwuma, Arinze S. Okoli, Bertrand Sagnia, Rebecca Chinyelu Chukwuanukwu, Denis M. Tebit, Charles Okechukwu Esimone, Alain Bopda Waffo, Chae Gyu Park, Klaus Überla, Godwin Nchinda
Abstract
Thus, complementary prime boost vaccination, in which prime and boost favor distinct types of T cell immunity, improves viral vectored immunization, including mobilization of protective CD8+ T cells to a pathogenic virus infection site such as the murine airway.
Related Papers
- → Comparative efficacy of LaSota, B1 and Mukteswar Strain vaccines for Newcastle Disease Virus (NDV) in layer chickens(2021)2 cited
- → Newcastle Disease Immunization Studies(1957)53 cited
- → A Study on the Epizootiology of Newcastle Disease (Pneumoencephalitis)(1949)6 cited
- Plaque-purification of newcastle disease GM2 isolates and determination of biological characteristics(2009)
- Establishment of RT-LAMP system for rapid detection of Newcastle disease virus in duck(2011)